This webinar will review the current state of the understanding of the immune response to hepatitis b (HBV). Two experts and one moderator will guide providers through an understanding of the HBV immune interactions that can help providers understand and help explain HBV infections, guide patient management and help embrace new therapies.Rachel Church (Moderator) Rachel Church, PhD is a Research Assistant Professor in the Department of Pharmacotherapy and Experimental Therapeutics within the Eshelman School of Pharmacy at the University of North Carolina, Chapel Hill.

Christine Baechlein, Paul Becher – 7 October 2016

Fen Huang, Yunlong Li, Wenhai Yu, Chenchen Yang – 7 October 2016

Jean C. Emond, Adam D. Griesemer – 7 October 2016

David B. Haslam – 7 October 2016

The evidence to support therapeutic decisions in patients with cirrhosis and fundal and ectopic varices is scarce, and treatment is controversial. In addition, since these varices are infrequent, clinicians have limited experience and knowledge of the therapeutic options.

Gregory J. Dore – 6 October 2016

Sarwa Darwish Murad, Edith M. Koehler, Elisabeth P.C. Plompen, Harry L.A. Janssen – 6 October 2016

Cheng‐Maw Ho, Hui‐Ling Chen – 6 October 2016

Christophe Renou, Bruno Lesgourgues, Gilles Macaigne, Arnaud Pauwels, Yann Le Bricquir, Jean Henrion, Faiza Khemissa, Emma Clair, Thierry Paupard, Agnes Pelaquier, Hélène Agostini, Anne‐Marie Roque‐Afonso – 6 October 2016